Inhibition of Parkinson's disease-related LRRK2 by type I and type II kinase inhibitors: Activity and structures
Sanz Murillo M, Villagran Suarez A, Dederer V, Chatterjee D, Alegrio Louro J, Knapp S, Mathea S, Leschziner AE
Science advances 9 (2023)